JAZZ
Jazz Pharmaceuticals PLC
238.00$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.6% | 40.2% | 39.7% | 42.8% | 42.2% | 35.9% | 38.1% | 25.2% | 34.8% | 28.5% | 34.3% | 31.8% | |
| 11.4% | 8.2% | 7.6% | 10.2% | 11.5% | 17.1% | 11.8% | 17.9% | 17.2% | 16.7% | 16.2% | 16.3% | |
| 5.9% | 6.9% | 6.6% | 6.6% | 5.4% | 5.1% | 5.1% | 6.1% | 6.1% | 5.9% | 6.1% | 6.8% | |
| 5.8% | 4.6% | 3.8% | -6.3% | 3.5% | -0.4% | 6.6% | 19.5% | 3.8% | – | – | – | |
| -4.4% | -0.5% | -1.5% | 1.7% | 1.2% | -6.9% | -3.6% | -1.5% | 0.3% | -5.3% | -1.9% | 0.4% | |
| 20.4% | 2.7% | 12.2% | 7.0% | 7.0% | 8.4% | 16.0% | 1.5% | 13.6% | 0.6% | 1.2% | 4.9% | |
| -91.0% | -0.2% | -117.6% | -16.6% | -20.9% | -7.2% | -42.6% | -168.4% | -12.2% | -4.3% | -12.5% | -35.4% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 2.7% | 4.2% | 3.2% | 2.7% | – | – | – | |
| -3.6% | -4.6% | -18.7% | -6.1% | -27.7% | -13.9% | -6.2% | -1.2% | 0.0% | -7.0% | -7.7% | -2.9% | |
| 75.4% | -12.6% | 54.9% | -20.2% | -1.7% | -1.5% | 25.0% | 125.1% | -15.9% | -0.8% | 9.2% | -18.3% | |
| 60.8% | -16.2% | 36.4% | -25.3% | -25.3% | -13.6% | 22.3% | 128.3% | -14.5% | -8.0% | 0.5% | -20.5% | |
| 4.1% | 23.0% | -41.9% | 1.2% | -4.0% | 15.2% | 17.8% | -15.1% | 7.9% | 16.3% | 22.3% | -23.9% | |
| 14.2% | 37.4% | 27.5% | 35.8% | 35.3% | 27.5% | 22.0% | 23.7% | 21.1% | 27.9% | 33.1% | 26.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.